AYTU
Price
$2.13
Change
+$0.08 (+3.90%)
Updated
Dec 3 closing price
Capitalization
21.7M
Intraday BUY SELL Signals
VTRS
Price
$10.84
Change
+$0.13 (+1.21%)
Updated
Dec 3 closing price
Capitalization
12.49B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AYTU vs VTRS

Header iconAYTU vs VTRS Comparison
Open Charts AYTU vs VTRSBanner chart's image
Aytu BioPharma
Price$2.13
Change+$0.08 (+3.90%)
Volume$44.73K
Capitalization21.7M
Viatris
Price$10.84
Change+$0.13 (+1.21%)
Volume$5.62M
Capitalization12.49B
AYTU vs VTRS Comparison Chart in %
AYTU
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AYTU vs. VTRS commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Hold and VTRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (AYTU: $2.07 vs. VTRS: $10.71)
Brand notoriety: AYTU and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 21% vs. VTRS: 39%
Market capitalization -- AYTU: $21.7M vs. VTRS: $12.49B
AYTU [@Pharmaceuticals: Generic] is valued at $21.7M. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $12.49B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • AYTU’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, both AYTU and VTRS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 5 TA indicator(s) are bullish while VTRS’s TA Score has 3 bullish TA indicator(s).

  • AYTU’s TA Score: 5 bullish, 4 bearish.
  • VTRS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AYTU is a better buy in the short-term than VTRS.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -2.02% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +1.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.67%. For the same industry, the average monthly price growth was +0.42%, and the average quarterly price growth was +25.91%.

Reported Earning Dates

VTRS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.67% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($12.5B) has a higher market cap than AYTU($21.7M). AYTU YTD gains are higher at: 21.900 vs. VTRS (-10.642). AYTU has higher annual earnings (EBITDA): 10.6M vs. VTRS (-493.3M). VTRS has more cash in the bank: 809M vs. AYTU (18.2M). AYTU has less debt than VTRS: AYTU (21.4M) vs VTRS (14.8B). VTRS has higher revenues than AYTU: VTRS (14.1B) vs AYTU (81.7M).
AYTUVTRSAYTU / VTRS
Capitalization21.7M12.5B0%
EBITDA10.6M-493.3M-2%
Gain YTD21.900-10.642-206%
P/E RatioN/A236.20-
Revenue81.7M14.1B1%
Total Cash18.2M809M2%
Total Debt21.4M14.8B0%
FUNDAMENTALS RATINGS
AYTU vs VTRS: Fundamental Ratings
AYTU
VTRS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8495
PRICE GROWTH RATING
1..100
4951
P/E GROWTH RATING
1..100
571
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (8) in the null industry is somewhat better than the same rating for AYTU (44) in the Other Consumer Services industry. This means that VTRS’s stock grew somewhat faster than AYTU’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as AYTU (100) in the Other Consumer Services industry. This means that VTRS’s stock grew similarly to AYTU’s over the last 12 months.

AYTU's SMR Rating (84) in the Other Consumer Services industry is in the same range as VTRS (95) in the null industry. This means that AYTU’s stock grew similarly to VTRS’s over the last 12 months.

AYTU's Price Growth Rating (49) in the Other Consumer Services industry is in the same range as VTRS (51) in the null industry. This means that AYTU’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is somewhat better than the same rating for AYTU (57) in the Other Consumer Services industry. This means that VTRS’s stock grew somewhat faster than AYTU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUVTRS
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
69%
Bearish Trend 7 days ago
53%
Momentum
ODDS (%)
Bullish Trend 7 days ago
74%
Bearish Trend 7 days ago
56%
MACD
ODDS (%)
Bullish Trend 7 days ago
76%
Bearish Trend 7 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
59%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 7 days ago
69%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 15 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
67%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EHLD7.240.06
+0.77%
Euroholdings Ltd
BKR49.49-0.67
-1.34%
Baker Hughes Company
GAMB5.45-0.14
-2.42%
Gambling.com Group Limited
NAMS38.33-1.28
-3.23%
NewAmsterdam Pharma Company NV
MLTX12.54-0.71
-5.36%
MoonLake Immunotherapeutics

AYTU and

Correlation & Price change

A.I.dvisor tells us that AYTU and AMPH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
+0.60%
AMPH - AYTU
29%
Poorly correlated
-2.91%
TRUFF - AYTU
22%
Poorly correlated
N/A
VTRS - AYTU
21%
Poorly correlated
+0.09%
IMCC - AYTU
21%
Poorly correlated
-1.69%
PBH - AYTU
21%
Poorly correlated
-0.38%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+0.09%
ELAN - VTRS
50%
Loosely correlated
-0.53%
AMPH - VTRS
48%
Loosely correlated
-2.91%
AMRX - VTRS
48%
Loosely correlated
-2.48%
ZTS - VTRS
39%
Loosely correlated
-2.24%
ALKS - VTRS
38%
Loosely correlated
+0.24%
More